1 / 16

TOC - Global Cell-Free RNA Isolation and Extraction Market

The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.

bisreports
Download Presentation

TOC - Global Cell-Free RNA Isolation and Extraction Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Cell-Free RNA Isolation and Extraction Kits Market - A Global and Regional Analysis Table of Content GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Focus on Application, End User, and Region Analysis and Forecast: 2022-2032 August 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 16 1.Markets ..................................................................................... 21 1.1 Product Definition ............................................................................................ 22 1.1.1Inclusion and Exclusion Criteria ................................................................ 22 1.2 Market Scope ................................................................................................... 22 1.2.1Scope of the Study ...................................................................................... 22 1.2.2Key Questions Answered in the Report .................................................... 23 1.3 Research Methodology ................................................................................... 24 1.3.1Global cell-free RNA isolation and extraction kits market: Research Methodology ................................................................................................ 24 1.3.2Data Sources ............................................................................................... 25 1.3.2.1 Primary Data Sources ........................................................................................ 25 1.3.2.2 Secondary Data Sources ................................................................................... 25 1.3.3Market Estimation Model ............................................................................ 26 1.3.4Criteria for Company Profiling ................................................................... 28 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 1.4 Market Overview .............................................................................................. 28 1.4.1Introduction: Cell-Free RNA ....................................................................... 28 1.4.2Emergence of Cell-Free RNA ...................................................................... 29 1.4.3Spin Column-Based Technology ............................................................... 30 1.4.4Magnetic Bead-Based Technology ............................................................ 31 1.4.5Market Size and Growth Potential, $Million, 2021-2032 ........................... 31 1.5 Patent Landscape ............................................................................................ 32 1.5.1Patent Filing Trend ...................................................................................... 32 1.5.2Patent Analysis (by Year) ........................................................................... 33 1.5.3Patent Analysis (by Country) ..................................................................... 34 1.5.4Patent Analysis (by Region) ....................................................................... 35 2.Industry Analysis ....................................................................... 36 2.1 Overview ........................................................................................................... 37 3 All rights reserved at BIS Research Inc.

  4. 2.2 Regulatory Framework in the U.S. ................................................................. 37 2.2.1FDA Regulations .......................................................................................... 37 2.3 Regulatory Framework in the European Union (EU) .................................... 39 2.4 Regulatory Framework in Asia-Pacific .......................................................... 40 2.4.1China ............................................................................................................ 40 2.4.2Japan ............................................................................................................ 42 3.Market Dynamics ....................................................................... 43 3.1 Market Dynamics ............................................................................................. 44 3.1.1Overview ...................................................................................................... 44 3.2 Impact Analysis ............................................................................................... 44 3.3 Market Drivers .................................................................................................. 46 3.3.1Increasing Incidence of Cancer.................................................................. 46 3.3.2Increasing Number of Cases with Prenatal Complications ..................... 47 3.3.3Advancement in the RNA Sequencing Technology ................................. 49 3.4 Market Restraints ............................................................................................. 50 3.4.1Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods ............................................................................................... 50 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 3.4.2Ethical, Legal, and Social Issues Associated with Prenatal Screening ..................................................................................................... 50 3.5 Market Opportunities ....................................................................................... 52 3.5.1Growth in Emerging Nations ...................................................................... 52 3.5.2Rising Funding Activities for Cell-Free RNA Biomarkers ........................ 52 4.Competitive Landscape ............................................................. 54 4.1 Overview ........................................................................................................... 55 4.1.1Corporate Strategies ................................................................................... 55 4.1.1.1 Synergistic Activities .......................................................................................... 55 4.1.2Business Strategies .................................................................................... 56 4.1.2.1 Product Launches .............................................................................................. 56 4.2 Market Share Analysis .................................................................................... 57 4 All rights reserved at BIS Research Inc.

  5. Growth-Share Analysis (by Company) .......................................................... 59 5.Application, $Million, 2021-2032 ................................................. 61 4.3 5.1 Overview ........................................................................................................... 62 5.2 Oncology .......................................................................................................... 63 5.3 Prenatal Screening (Preeclampsia) ................................................................ 64 5.4 Metabolic Disorders ........................................................................................ 65 6.End Users, $Million, 2021-2032 .................................................. 66 6.1 Overview ........................................................................................................... 67 6.2 Academic Research Institutions and Laboratories ...................................... 68 6.3 Hospitals........................................................................................................... 69 6.4 Pharmaceutical and Biotechnology Companies ........................................... 70 6.5 Diagnostic Laboratories .................................................................................. 71 7.Region, $Million, 2021-2032 ....................................................... 72 7.1 Overview ........................................................................................................... 73 7.2 North America .................................................................................................. 75 7.3 Europe .............................................................................................................. 77 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 7.4 Asia-Pacific (APAC) ......................................................................................... 79 7.5 Latin America ................................................................................................... 82 Rest-of-the-World ............................................................................................ 84 8. Company Profiles ...................................................................... 85 7.6 8.1 Overview ........................................................................................................... 86 8.2 Aline Biosciences ............................................................................................ 87 8.2.1Company Overview ..................................................................................... 87 8.2.2Role of Aline Biosciences in the Global Cell-Free RNA Isolation and Extraction Kits Market ................................................................................. 87 8.2.3Key Competitors of the Company .............................................................. 88 8.2.4Analyst Perspective .................................................................................... 88 8.3 Apostle Sciences ............................................................................................. 89 5 All rights reserved at BIS Research Inc.

  6. 8.3.1Company Overview ..................................................................................... 89 8.3.2Role of Apostle Sciences in the Global Cell-Free RNA Isolation and Extraction Kits Market ................................................................................. 89 8.3.3Key Competitors of the Company .............................................................. 90 8.3.4Analyst Perspective .................................................................................... 90 8.4 Danagen-Bioted, S.L. ....................................................................................... 91 8.4.1Company Overview ..................................................................................... 91 8.4.2Role of Danagen-Bioted, S.L. in the Global Cell-Free RNA Isolation and Extraction Kits Market ......................................................................... 91 8.4.3Key Competitors of the Company .............................................................. 92 8.4.4Analyst Perspective .................................................................................... 92 8.5 F. Hoffmann-La Roche Ltd. ............................................................................. 93 8.5.1Company Overview ..................................................................................... 93 8.5.2Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free RNA Isolation and Extraction Kits Market .......................................................... 93 8.5.3Key Customers of the Company ................................................................ 94 8.5.4Key Competitors of the Company .............................................................. 94 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 8.5.5Financials ..................................................................................................... 94 8.5.6Analyst Perspective .................................................................................... 97 8.6 JBS Science Inc. .............................................................................................. 98 8.6.1Company Overview ..................................................................................... 98 8.6.2Role of JBS Science Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market ................................................................................. 98 8.6.3Key Competitors of the Company .............................................................. 99 8.6.4Corporate Strategies ................................................................................... 99 8.6.4.1 Synergistic Activities .......................................................................................... 99 8.6.4.1.1Agreement ................................................................................................................ 99 8.6.5Analyst Perspective .................................................................................... 99 8.7 Norgen Biotek Corp. ...................................................................................... 100 6 All rights reserved at BIS Research Inc.

  7. 8.7.1Company Overview ................................................................................... 100 8.7.2Role of Norgen Biotek Corp. in the Global Cell-Free RNA Isolation and Extraction Kits Market ....................................................................... 100 8.7.3Key Customers of the Company .............................................................. 101 8.7.4Key Competitors of the Company ............................................................ 101 8.7.5Business Strategies .................................................................................. 101 8.7.5.1 Product Launch ................................................................................................ 101 8.7.6Analyst Perspective .................................................................................. 101 8.8 PerkinElmer, Inc. ............................................................................................ 103 8.8.1Company Overview ................................................................................... 103 8.8.2Role of PerkinElmer, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market ............................................................................... 103 8.8.3Key Customers of the Company .............................................................. 104 8.8.4Key Competitors of the Company ............................................................ 104 8.8.5Financials ................................................................................................... 105 8.8.6Key Insights about the Financial Health of the Company ...................... 107 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 8.8.7Analyst Perspective .................................................................................. 107 8.9 Promega Corporation .................................................................................... 108 8.9.1Company Overview ................................................................................... 108 8.9.2Role of Promega Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market ....................................................................... 108 8.9.3Key Competitors of the Company ............................................................ 109 8.9.4Business Strategies .................................................................................. 109 8.9.4.1 Product Launch ................................................................................................ 109 8.9.5Analyst Perspective .................................................................................. 109 8.10QIAGEN N.V. ................................................................................................... 110 8.10.1Company Overview ................................................................................... 110 8.10.2Role of QIAGEN N.V. in the Global Cell-Free RNA Isolation and Extraction Kits Market ............................................................................... 110 8.10.3Key Customers of the Company .............................................................. 111 7 All rights reserved at BIS Research Inc.

  8. 8.10.4Key Competitors of the Company ............................................................ 111 8.10.5Financials ................................................................................................... 112 8.10.6Key Insights About the Financial Health of the Company ..................... 114 8.10.7Business Strategies .................................................................................. 114 8.10.7.1 Product Launch ................................................................................................ 114 8.10.8Analyst Perspective .................................................................................. 115 8.11Streck, Inc....................................................................................................... 116 8.11.1Company Overview ................................................................................... 116 8.11.2Role of Streck, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market ............................................................................... 116 8.11.3Key Customers of the Company .............................................................. 117 8.11.4Key Competitors of the Company ............................................................ 117 8.11.5Business Strategies .................................................................................. 117 8.11.5.1 Product Launch ................................................................................................ 117 8.11.6Analyst Perspective .................................................................................. 117 8.12Thermo Fisher Scientific Inc. ........................................................................ 118 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 8.12.1Company Overview ................................................................................... 118 8.12.2Role of Thermo Fisher Scientific Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market ........................................................ 118 8.12.3Key Customers of the Company .............................................................. 119 8.12.4Key Competitors of the Company ............................................................ 119 8.12.5Financials ................................................................................................... 120 8.12.6Key Insights About the Financial Health of the Company ..................... 122 8.12.7Analyst Perspective .................................................................................. 122 8.13Takara Bio Inc. ............................................................................................... 123 8.13.1Company Overview ................................................................................... 123 8.13.2Role of Takara Bio Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market ............................................................................... 123 8.13.3Key Customers of the Company .............................................................. 124 8 All rights reserved at BIS Research Inc.

  9. 8.13.4Key Competitors of the Company ............................................................ 124 8.13.5Financials ................................................................................................... 125 8.13.6Analyst Perspective .................................................................................. 127 8.14Zymo Research Corporation ......................................................................... 128 8.14.1Company Overview ................................................................................... 128 8.14.2Role of Zymo Research Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market ........................................................ 128 8.14.3Key Competitors of the Company ............................................................ 129 8.14.4Analyst Perspective .................................................................................. 129 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 9 All rights reserved at BIS Research Inc.

  10. List of Figures Figure 1:Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021 and 2032 Figure 2:Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation Figure 3:Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032 Figure 4:Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032 Figure 5:Global Cell-Free RNA Isolation and Extraction Kits Market (by Region) Figure 6:Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation Figure 7:Global Cell-Free RNA Isolation and Extraction Kits Market: Research Methodology Figure 8:Primary Research Methodology Figure 9:Bottom-Up Approach (Segment-Wise Analysis) Figure 10:Top-Down Approach (Segment-Wise Analysis) Figure 11:Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032 Figure 12:Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Year), January 2019-June 2022 Figure 13:Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Country), January 2019-June 2022 Figure 14:Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Region), January GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 2019-June 2022 Figure 15:FDA Classification for Medical Devices Figure 16:Overview of Regulatory Process for Medical Devices in the U.S. Figure 17:Overview of Regulatory Process in the European Union (EU) Figure 18:Overview of Regulatory Process for Medical Devices in China Figure 19:Global Cell-Free RNA Isolation and Extraction Kits Market Dynamics Figure 20:Global Cancer Incidence, 2017-2021 Figure 21:Maternal Mortality Rate, Region-Wise, 2020 Figure 22:Maternal Mortality Rate in the U.S. Figure 23:Ethical, Legal, and Social Issues Figure 24:Funding Scenario in the Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, January 2019-February 2022 Figure 25:Share of Key Developments, January 2019-February 2022 Figure 26:Share of Product Launches and Upgrades (by Company), January 2019-February 2022 10 All rights reserved at BIS Research Inc.

  11. Figure 27:Market Share Analysis of Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2020 and 2021 Figure 28:Growth-Share Analysis for Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2021 Figure 29:Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032 Figure 30:Global Cell-Free RNA Isolation and Extraction Kits Market (Oncology), $Million, 2021-2032 Figure 31:Global Cell-Free RNA Isolation and Extraction Kits Market (Prenatal Screening), $Million, 2021- 2032 Figure 32:Global Cell-Free RNA Isolation and Extraction Kits Market (Metabolic Disorders), $Million, 2021- 2032 Figure 33:Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032 Figure 34:Global Cell-Free RNA Isolation and Extraction Kits Market (Academic Research Institutions and Laboratories), 2021-2032 Figure 35:Global Cell-Free RNA Isolation and Extraction Kits Market (Hospitals), 2021-2032 Figure 36:Global Cell-Free RNA Isolation and Extraction Kits Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032 Figure 37:Global Cell-Free RNA Isolation and Extraction Kits Market (Diagnostic Laboratories), $Million, 2021-2032 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Figure 38:Global Cell-Free RNA Isolation and Extraction Kits Market (by Region) Figure 39:Global Cell-Free RNA Isolation and Extraction Kits Market (by Region), 2021 and 2032 Figure 40:North America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032 Figure 41:Europe Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032 Figure 42:Asia-Pacific Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032 Figure 43:Latin America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032 Figure 44:Rest-of-the-World Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032 Figure 45:Total Number of Companies Profiled Figure 46:Aline Biosciences: Product Portfolio Figure 47:Apostle Sciences: Product Portfolio Figure 48:Danagen-Bioted, S.L.: Product Portfolio Figure 49:F. Hoffmann-La Roche Ltd.: Product Portfolio Figure 50:F. Hoffmann-La Roche Ltd.: Overall Financials, 2019-2021 Figure 51:F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021 Figure 52:F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021 Figure 53:F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021 11 All rights reserved at BIS Research Inc.

  12. Figure 54:JBS Science Inc.: Product Portfolio Figure 55:Norgen Biotek Corp.: Product Portfolio Figure 56:PerkinElmer, Inc.: Product Portfolio Figure 57:PerkinElmer, Inc.: Overall Financials, $Million, 2019-2021 Figure 58:PerkinElmer, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 59:PerkinElmer, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 60:PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 61:Promega Corporation: Product Portfolio Figure 62:QIAGEN N.V.: Product Portfolio Figure 63:QIAGEN N.V.: Overall Financials, $Million, 2019-2021 Figure 64:QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021 Figure 65:QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021 Figure 66:QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021 Figure 67:Streck, Inc.: Product Portfolio Figure 68:Thermo Fisher Scientific Inc.: Product Portfolio Figure 69:Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021 Figure 70:Company Name: Revenue (by Segment), $Million, 2019-2021 GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Figure 71:Company Name: Revenue (by Region), $Million, 2019-2021 Figure 72:Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021 Figure 73:Takara Bio Inc.: Product Portfolio Figure 74:Takara Bio Inc.: Overall Financials, 2019-2022 Figure 75:Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2022 Figure 76:Takara Bio Inc.: Revenue (by Region), $Million, 2019-2022 Figure 77:Takara Bio Inc.: R&D Expenditure, $Million, 2019-2022 Figure 78:Zymo Research Corporation: Product Portfolio 12 All rights reserved at BIS Research Inc.

  13. List of Tables Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market Table 2: Different Types of Cell-Free RNA in Serum/Plasma Table 3: Examples of Spin-Column Technology-Based Cell-Free RNA Isolation and Extraction Kits Table 4: Examples of Magnetic-Bead Technology Based Cell-Free RNA Isolation and Extraction Kits Table 5: Likert Scale Table 6: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET 13 All rights reserved at BIS Research Inc.

  14. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Know More Know More Know More Know More 14 All rights reserved at BIS Research Inc.

  15. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of information to generate any statistical or other information that is or will be provided to third parties, or voluntarily produce information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties, and contingencies. For more details regarding permission, please contact us: GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET Email: sales@bisresearch.com Tel: +1 510 404 8135 15 All rights reserved at BIS Research Inc.

  16. GLOBAL CELL-FREE RNA ISOLATION AND EXTRACTION KITS MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 16 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related